rs150132566

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198576.4(AGRN):ā€‹c.3264G>Cā€‹(p.Leu1088Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00735 in 1,585,702 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1088?) has been classified as Benign.

Frequency

Genomes: š‘“ 0.013 ( 24 hom., cov: 33)
Exomes š‘“: 0.0068 ( 50 hom. )

Consequence

AGRN
NM_198576.4 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.22
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029761791).
BP6
Variant 1-1046833-G-C is Benign according to our data. Variant chr1-1046833-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 128298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-1046833-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0128 (1954/152294) while in subpopulation AFR AF= 0.0309 (1285/41558). AF 95% confidence interval is 0.0295. There are 24 homozygotes in gnomad4. There are 894 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AGRNNM_198576.4 linkuse as main transcriptc.3264G>C p.Leu1088Phe missense_variant 19/36 ENST00000379370.7 NP_940978.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkuse as main transcriptc.3264G>C p.Leu1088Phe missense_variant 19/361 NM_198576.4 ENSP00000368678 P1O00468-6
AGRNENST00000651234.1 linkuse as main transcriptc.2949G>C p.Leu983Phe missense_variant 18/38 ENSP00000499046
AGRNENST00000652369.1 linkuse as main transcriptc.2949G>C p.Leu983Phe missense_variant 18/35 ENSP00000498543
AGRNENST00000620552.4 linkuse as main transcriptc.2850G>C p.Leu950Phe missense_variant 19/395 ENSP00000484607

Frequencies

GnomAD3 genomes
AF:
0.0127
AC:
1931
AN:
152176
Hom.:
24
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0305
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.00549
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00748
Gnomad OTH
AF:
0.0115
GnomAD3 exomes
AF:
0.00645
AC:
1299
AN:
201354
Hom.:
4
AF XY:
0.00597
AC XY:
652
AN XY:
109230
show subpopulations
Gnomad AFR exome
AF:
0.0285
Gnomad AMR exome
AF:
0.00406
Gnomad ASJ exome
AF:
0.00321
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00239
Gnomad FIN exome
AF:
0.00135
Gnomad NFE exome
AF:
0.00769
Gnomad OTH exome
AF:
0.00543
GnomAD4 exome
AF:
0.00677
AC:
9701
AN:
1433408
Hom.:
50
Cov.:
39
AF XY:
0.00664
AC XY:
4721
AN XY:
710890
show subpopulations
Gnomad4 AFR exome
AF:
0.0285
Gnomad4 AMR exome
AF:
0.00450
Gnomad4 ASJ exome
AF:
0.00337
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00349
Gnomad4 FIN exome
AF:
0.00134
Gnomad4 NFE exome
AF:
0.00688
Gnomad4 OTH exome
AF:
0.00745
GnomAD4 genome
AF:
0.0128
AC:
1954
AN:
152294
Hom.:
24
Cov.:
33
AF XY:
0.0120
AC XY:
894
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.0309
Gnomad4 AMR
AF:
0.00549
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00580
Gnomad4 FIN
AF:
0.000659
Gnomad4 NFE
AF:
0.00748
Gnomad4 OTH
AF:
0.0114
Alfa
AF:
0.00533
Hom.:
2
Bravo
AF:
0.0141
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.0289
AC:
126
ESP6500EA
AF:
0.00747
AC:
64
ExAC
AF:
0.00616
AC:
735
Asia WGS
AF:
0.00722
AC:
25
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMar 22, 2021- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingGeneDxJan 09, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJan 02, 2017- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Congenital myasthenic syndrome 8 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.0030
DANN
Benign
0.43
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.4
FATHMM_MKL
Benign
0.0089
N
LIST_S2
Benign
0.073
T;T
MetaRNN
Benign
0.0030
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.90
L;.
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
0.59
N;.
REVEL
Benign
0.14
Sift
Benign
0.72
T;.
Sift4G
Benign
0.73
T;T
Vest4
0.074
MutPred
0.081
Gain of glycosylation at S1091 (P = 0.1278);.;
MVP
0.45
MPC
0.13
ClinPred
0.0021
T
GERP RS
-8.4
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.7
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150132566; hg19: chr1-982213; COSMIC: COSV65067856; COSMIC: COSV65067856; API